Lozartan Plus - winner of the tender for all dosages

In May and June 2018, the medicinal preparation Lozartan Plus JLLC Lekpharm was awarded contracts for the purchase of the Republic of Belarus for all three dosages in the international non-proprietary name Losartan + Hydrochlorothiazide.

Losartan Plus is the only domestic fixed combination of losartan and hydrochlorothiazide.

The novelty is available in three dosages of 50 mg / 12.5 mg, 100 mg / 12.5 mg, 100 mg / 25 mg, as tablets coated, 30 tablets per package.

The combination of two drugs (angiotensin II receptor blocker + diuretic hydrochlorothiazide) with different mechanisms of action in one Lozartan Plus tablet and convenient administration once a day makes it possible to greatly simplify the treatment of those patients with hypertension who need combination therapy.

Information on the award of the contract can be found at https://pharma.by/partners/information/